Medicare Negotiates 71% Discount on Novo’s Ozempic, Wegovy (1)

The US government said Tuesday it negotiated a 71% discount off of the list price of Novo Nordisk A/S’s blockbuster drugs Ozempic and Wegovy for patients in Medicare, the federal health insurance program for the elderly.